Shukra Pharmaceuticals
Board Meeting Intimation for Un-Audited Financial Results For The Quarter Ended September 2026
Filed with BSE ·
6ix is reading this filing.
View original source (BSE India)Shukra Pharmaceuticals Ltd. on 6ix
Earlier from Shukra Pharmaceuticals
- Announcement under Regulation 30 (LODR)-Change of Company Name
- Board Meeting Outcome for Allotment Of Shares Pursuant To Conversion Of Warrants
- Clarification From The Company
- Shukra Pharmaceuticals Ltd. Press Release Sep 29 2026
- Shukra Pharmaceuticals Ltd. Press Release Sep 28 2026
Follow Shukra Pharmaceuticals into a list and get an email when it puts out news.
Follow Shukra Pharmaceuticals